ALEC
Alector, Inc.
$1.61
-0.03 (-1.53%)
At close · Jul 10
Market Cap
$178.75M
Shares
111,025,187
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.61
Open$1.63
Day$1.48–1.66
52W$1.09–3.40
Avg vol 30d866K
Short int5.7M · 5.1% float · 4.4d
Short vol70%
Last earningsAug 7, 2025
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Neutral
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−20%
below
Price vs 50-day avg
−19%
below
RSI (14)
37
neutral
MACD trend
Negative
52-week position
23%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−12%
trailing
YTD return
+3%
this year
Relative strength
−21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Flat
1 of 137 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$233.0K over 90 days · 100% sells
Short interest
Rising
5.15% of float · ▲ +8.9% MoM · 4.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
137 holders — mid 3-yr range
Squeeze score
48
elevated · 0–100
Fundamentals
Revenue growth
−79%
Y/Y
EPS growth
−13%
Y/Y
Free cash flow
$-184.1M
Balance sheet
$55.8M
net cash
Quant / Vol
risk profile
Volatility
103%
annualized · 1-yr
Max drawdown
−66%
past year
ATR
10.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−20%
Bearish
Price vs 50-day avg
−19%
Bearish
RSI (14)
37
Neutral
MACD trend
Negative
Bearish
52-week position
23%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
Death cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Flat
1 of 137 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$233.0K over 90 days · 100% sells
Short interest
Rising
5.15% of float · ▲ +8.9% MoM · 4.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
137 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 23%
52-wk high $3
vs 200-day avg -20%
vs 50-day avg -19%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALEC
this stock
Alector, Inc.
|
$178.75M | +3.2% | -79.1% | — | 5.1% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALEC | -21.8% | +5.9% | -11.5% | -19.9% | +3.2% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -23.2% | +1.9% | -20.6% | -21.0% | -7.5% |